CP and pancreatic neoplasm: For inhibiting the proliferation of pancreatic cancer cells, Mito-CP and a synthetic cationic acetamide analog (Mito-CP-Ac) suppressed cellular energy metabolism function (Cheng et al., 2015), activated AMPK energy-sensing pathway, and changed the roles of glycolysis and citrate in mitochondrial bioenergy metabolism.